Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 16, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2021. Go to the latest filing (Q3 2026)

32.9B USDQ2 2021
Total value of stock positions
32.9B USD
Positions
87
Share of the ten largest
36.8%

The ten largest positions Q2 2021

  1. Amazon 5.0%▲ +161.9%
  2. Bridgebio Pharma Inc 4.9%unchanged
  3. Fidelity National Information Services 4.0%▼ −4.1%
  4. Microsoft 3.8%▼ −45.3%
  5. GE Aerospace 3.8%▲ +51.3%
  6. Adaptive Biotechnologies Cor 3.7%unchanged
  7. T-Mobile US 3.3%▼ −26.7%
  8. Palo Alto Networks 3.0%▲ +5.3%
  9. Coupa Software Inc 2.9%▲ +100.6%
  10. Fortive 2.5%▲ +5.3%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2021

Positions Q2 2021 per 13F filing, 87 of 87
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 5.0% 474,217 1.6B USD +161.9% increased Q2 2015 25 quarters
MSFT Microsoft 3.8% 4,655,350 1.3B USD −45.3% reduced Q2 2016 21 quarters
V Visa Inc. 1.6% 2,219,163 518.9M USD −45.0% reduced Q3 2016 20 quarters
Catalent Inc 0.4% 1,118,465 120.9M USD +48.3% increased Q1 2018 14 quarters
CNC Centene Corporation 2.5% 11,199,941 816.8M USD +2.0% increased Q2 2018 13 quarters
AON Aon plc 2.1% 2,903,054 693.1M USD +34.7% increased Q3 2018 12 quarters
BSX Boston Scientific 1.7% 13,315,816 569.4M USD −25.6% reduced Q3 2018 12 quarters
Bridgebio Pharma Inc 4.9% 26,620,991 1.6B USD unchanged Q2 2019 9 quarters
Adaptive Biotechnologies Cor 3.7% 29,993,708 1.2B USD unchanged Q2 2019 9 quarters
Avantor Inc 1.3% 11,732,062 416.6M USD −24.3% reduced Q2 2019 9 quarters
AIZ Assurant 1.1% 2,411,046 376.6M USD −13.1% reduced Q2 2019 9 quarters
FTV Fortive 2.5% 11,778,211 821.4M USD +5.3% increased Q3 2019 8 quarters
Guardant Health Inc 1.6% 4,256,363 528.6M USD +45.9% increased Q3 2019 8 quarters
Molina Healthcare Inc 0.7% 973,356 246.3M USD −32.1% reduced Q3 2019 8 quarters
FIS Fidelity National Information Services 4.0% 9,200,315 1.3B USD −4.1% reduced Q4 2019 7 quarters
TMUS T-Mobile US 3.3% 7,542,189 1.1B USD −26.7% reduced Q1 2020 6 quarters
CB Chubb Limited 2.4% 4,920,334 782.0M USD +17.7% increased Q1 2020 6 quarters
IR Ingersoll Rand 1.0% 6,417,254 313.2M USD +19.5% increased Q1 2020 6 quarters
Horizon Therapeutics Pub L 0.3% 1,170,211 109.6M USD −44.7% reduced Q1 2020 6 quarters
Api Group Corp 2.1% 33,333,333 696.3M USD unchanged Q2 2020 5 quarters
TMO Thermo Fisher Scientific 1.5% 1,011,401 510.2M USD +17.3% increased Q2 2020 5 quarters
ALGN Align Technology 0.7% 404,087 246.9M USD −25.8% reduced Q2 2020 5 quarters
PH Parker Hannifin 0.6% 666,117 204.6M USD −18.6% reduced Q2 2020 5 quarters
Royalty Pharma PLC 0.4% 3,238,654 132.8M USD +57.1% increased Q2 2020 5 quarters
Zentalis Pharmaceuticals Inc 0.4% 2,399,284 127.6M USD unchanged Q2 2020 5 quarters
Pvh Corporation 0.2% 639,474 68.8M USD −31.5% reduced Q2 2020 5 quarters
BMY Bristol Myers Squibb 2.3% 11,317,752 756.3M USD +117.8% increased Q3 2020 4 quarters
Fleetcor Technologies Inc 2.2% 2,872,814 735.6M USD +9.1% increased Q3 2020 4 quarters
ZBH Zimmer Biomet 1.4% 2,954,171 475.1M USD −22.7% reduced Q3 2020 4 quarters
PODD Insulet Corporation 1.3% 1,595,288 437.9M USD +54.0% increased Q3 2020 4 quarters
Laboratory Corp Amer HLDGS 1.2% 1,373,414 378.9M USD +27.0% increased Q3 2020 4 quarters
Inhibrx Inc 0.4% 5,305,866 146.0M USD unchanged Q3 2020 4 quarters
GOOGL Alphabet Inc. (Class A) 0.4% 54,637 133.4M USD −88.0% reduced Q3 2020 4 quarters
SNOW Snowflake 0.4% 545,741 132.0M USD −13.0% reduced Q3 2020 4 quarters
Karuna Therapeutics Inc 0.3% 822,465 93.8M USD +36.8% increased Q3 2020 4 quarters
Pmv Pharmaceuticals Inc 0.2% 1,790,284 61.2M USD −14.2% reduced Q3 2020 4 quarters
Pacific Biosciences Calif In 0.1% 1,273,659 44.5M USD +334.2% increased Q3 2020 4 quarters
GE GE Aerospace 3.8% 91,790,079 1.2B USD +51.3% increased Q4 2020 3 quarters
PANW Palo Alto Networks 3.0% 2,640,393 979.7M USD +5.3% increased Q4 2020 3 quarters
NOW ServiceNow 2.5% 1,482,387 814.6M USD +64.2% increased Q4 2020 3 quarters
UNH UnitedHealth Group 2.2% 1,798,650 720.3M USD −41.6% reduced Q4 2020 3 quarters
META Meta Platforms 2.1% 2,030,659 706.1M USD −13.5% reduced Q4 2020 3 quarters
Match Group Inc New 1.2% 2,356,406 380.0M USD +15.8% increased Q4 2020 3 quarters
MRSH Marsh McLennan 0.9% 2,057,461 289.4M USD −1.2% reduced Q4 2020 3 quarters
Acadia Healthcare Company In 0.4% 2,060,125 129.3M USD +24.7% increased Q4 2020 3 quarters
4D Molecular Therapeutics In 0.3% 3,937,914 94.8M USD unchanged Q4 2020 3 quarters
DASH DoorDash 0.3% 463,778 82.7M USD −24.0% reduced Q4 2020 3 quarters
Kinnate Biopharma Inc 0.1% 1,820,462 42.4M USD −2.8% reduced Q4 2020 3 quarters
BILI Bilibili < 0.1% 266,483 32.5M USD −42.5% reduced Q4 2020 3 quarters
Coupa Software Inc 2.9% 3,599,829 943.6M USD +100.6% increased Q1 2021 2 quarters
NFLX Netflix 1.4% 878,544 464.1M USD +17.1% increased Q1 2021 2 quarters
DE Deere & Company 1.4% 1,287,395 454.1M USD +84.9% increased Q1 2021 2 quarters
AMP Ameriprise Financial 1.2% 1,539,788 383.2M USD +81.6% increased Q1 2021 2 quarters
BAC Bank of America 0.9% 7,174,216 295.8M USD −77.1% reduced Q1 2021 2 quarters
Lithia Mtrs Inc 0.8% 807,493 277.5M USD +148.2% increased Q1 2021 2 quarters
Zai Lab Ltd 0.8% 1,539,257 272.4M USD +107.2% increased Q1 2021 2 quarters
RUN Sunrun 0.8% 4,464,114 249.0M USD +1.5% increased Q1 2021 2 quarters
Tenet Healthcare Corp 0.5% 2,279,182 152.7M USD +56.0% increased Q1 2021 2 quarters
SHOP Shopify 0.5% 104,441 152.6M USD −2.0% reduced Q1 2021 2 quarters
CRL Charles River Laboratories 0.4% 351,868 130.2M USD −21.6% reduced Q1 2021 2 quarters
Walgreens Boots Alliance Inc 0.3% 2,168,879 114.1M USD +26.3% increased Q1 2021 2 quarters
Edgewise Therapeutics Inc 0.2% 2,727,249 58.2M USD −18.6% reduced Q1 2021 2 quarters
Pharvaris N V 0.1% 2,391,517 43.5M USD −1.2% reduced Q1 2021 2 quarters
Orion Acquisition Corp 0.1% 3,597,342 35.7M USD −1.1% reduced Q1 2021 2 quarters
Gracell Biotechnologies Inc < 0.1% 1,330,328 17.3M USD −1.1% reduced Q1 2021 2 quarters
Figs Inc 2.3% 14,942,689 748.6M USD new Q2 2021 1 quarter
JD JD.com (ADR) 2.0% 8,241,079 657.7M USD new Q2 2021 1 quarter
Icici Bank Limited 1.1% 21,070,884 360.3M USD new Q2 2021 1 quarter
HUM Humana 0.8% 588,285 260.4M USD new Q2 2021 1 quarter
Brookfield Asset Mgmt Inc 0.6% 4,130,609 210.6M USD new Q2 2021 1 quarter
BKNG Booking Holdings 0.6% 90,093 197.1M USD new Q2 2021 1 quarter
XYZ Block, Inc. 0.5% 655,437 159.8M USD new Q2 2021 1 quarter
Intellia Therapeutics Inc 0.5% 975,092 157.9M USD new Q2 2021 1 quarter
TEAM Atlassian 0.4% 523,941 134.6M USD new Q2 2021 1 quarter
Zoominfo Technologies Inc 0.4% 2,381,274 124.2M USD new Q2 2021 1 quarter
Adapthealth Corp 0.3% 3,096,428 84.9M USD new Q2 2021 1 quarter
CHTR Charter Communications 0.2% 111,727 80.6M USD new Q2 2021 1 quarter
IFF International Flavors & Fragrances 0.2% 508,434 76.0M USD new Q2 2021 1 quarter
Peloton Interactive Inc 0.2% 524,792 65.1M USD new Q2 2021 1 quarter
Canadian Natl Ry Co 0.2% 537,655 56.7M USD new Q2 2021 1 quarter
Talaris Therapeutics Inc 0.1% 3,289,617 48.3M USD new Q2 2021 1 quarter
Mudrick Capital Acqu Corp II 0.1% 3,048,405 38.0M USD new Q2 2021 1 quarter
Day One Biopharmaceuticals I < 0.1% 1,341,396 30.5M USD new Q2 2021 1 quarter
Acceleron Pharma Inc < 0.1% 196,136 24.6M USD new Q2 2021 1 quarter
Kanzhun Limited < 0.1% 545,726 21.6M USD new Q2 2021 1 quarter
Smart Sh Global Ltd < 0.1% 470,000 2.9M USD new Q2 2021 1 quarter
Brookfield Asset Mgmt Reins < 0.1% 24,077 1.3M USD new Q2 2021 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 57.9M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Coupa Software Inc principal 50.0M USD 57.9M USD

Breakdown by sector

  • Health Care 15.0%
  • Financials 14.6%
  • Industrials 10.0%
  • Technology 9.7%
  • Communication Services 7.5%
  • Consumer Discretionary 5.8%
  • Materials 0.2%
  • not in our coverage 37.3%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close